Compare MASS & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MASS | MRLN |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.3M | 305.2M |
| IPO Year | 2020 | 2024 |
| Metric | MASS | MRLN |
|---|---|---|
| Price | $10.63 | $1.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $25.00 |
| AVG Volume (30 Days) | 379.7K | ★ 1.7M |
| Earning Date | 05-12-2026 | 10-28-2021 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.47 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $56,197,000.00 | N/A |
| Revenue This Year | $19.44 | N/A |
| Revenue Next Year | $18.63 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.03 | $2.02 |
| 52 Week High | $11.25 | $17.00 |
| Indicator | MASS | MRLN |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 25.79 |
| Support Level | $5.86 | N/A |
| Resistance Level | $10.52 | $3.59 |
| Average True Range (ATR) | 0.50 | 0.28 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 62.63 | 9.38 |
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.